Clinical Trial Update: DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial of DCVAC/OvCa with standard of care for relapsed ovarian/fallopian tube/peritoneal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Carcinoma

Drugs mentioned

• DCVAC/OvCa

Snippet

Sponsor: SOTIO a.s. | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Status: WITHDRAWN